Skip to main content
Fig. 5 | Annals of Intensive Care

Fig. 5

From: Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study

Fig. 5

Cumulative survival curve in severe COVID-19 patients with oseltamivir or ganciclovir. a Use of ganciclovir during hospital stay reduced the risk of death (hazard ratio, 0.20; 95% CI 0.07–0.55; p < 0.001). b Use of oseltamivir during hospital stay reduced the risk of death (hazard ratio, 0.21; 95% CI 0.10–0.43; p < 0.001)

Back to article page